USA New York Intellectual Property: Patent

Outstanding patent team recognized for its representation of prominent life sciences and electronics clients in high-profile patent litigation. Also possesses a leading IPR and PTAB practice. Maintains an excellent non-patent group, with substantial expertise in areas including trade dress, trademarks and false advertising matters. Additionally offers experience handling copyright infringement matters in the media and entertainment sectors.

Robust patent team with an excellent reputation for handling complex litigation in the life sciences and biotechnology sectors. Particular strength in prescription drug issues means that it is well placed to lead on developments in biologics. Offers additional strength advising on PTAB post-grant proceedings.

Notable litigation boutique with an excellent reputation for providing high-quality representation in patent disputes. Acts for clients in a range of industry sectors, including electronics and biotechnology.

Favored by recognized brands seeking patent litigators with deep courtroom experience for disputes across a spectrum of industries, including software, telecom and chemicals. Life sciences work for pharmaceuticals also represents a significant focus for the group.

Comes recommended for a deep knowledge of the pharmaceutical and wider life sciences sector. Particularly recognized for its Hatch-Waxman expertise. Also highly regarded for its experience in post-grant proceedings, appearing routinely in inter partes reviews and other PTAB matters for leading industry brands.

Excellent trial team sought after for its substantial expertise in handling pharmaceutical and life sciences patent disputes. Highly regarded for its work in USPTO proceedings, particularly post-grant proceedings. Demonstrates additional skill in advising on portfolio management and patent prosecution matters.

Strong patent litigation outfit, offering trial support in computing, electronics and life sciences, among other industries. Offers comprehensive counsel on patent portfolios as well as strong representation before the PTAB. Additionally possesses notable capabilities advising on IP commercialization matters. Represents a fine choice of firm for major universities, which regularly call upon the team for its patent prosecution and licensing expertise.

Recognized as a leading choice for clients in the life sciences arena, with a strong reputation for representing generic drug companies in Hatch-Waxman proceedings. Also esteemed for its work on behalf of electronics and technology clients, as well as those in the food and beverage and consumer products sectors.

Full-service practice group offering an excellent patent protection service and strength in IP issues related to corporate transactions. Offers notable strength handling high-value and complex patent disputes. Renowned for its experience in USPTO proceedings and district court litigation, frequently acting for clients in the life sciences and electronics spaces.

Superb trial lawyers with a strong track record in complex patent disputes. Offers particular expertise in the technology, medical devices and life sciences arenas, including in the emergent biologics space. Also possesses experience advising clients on transactional and commercial IP matters including portfolio exploitations and development issues.

Experienced in defending high-profile targets from lawsuits filed by nonpracticing entities. Also recognized for its advice on strategy and IP issues concerning transactions. Enjoys a fine track record for its work on behalf of electronics and telecommunications clients. Also adept at prosecuting patents in the pharmaceutical space, as well as handling Hatch-Waxman litigation.

Draws acclaim for its strong offering across the patent, trademark and copyright spaces. Possesses strength and depth in a number of areas including pharmaceuticals and biosimilars, boasting an impressive client roster of market-leading clients.

Fully immersed in the life sciences sector, handling litigation and providing transactional guidance on pharmaceutical, medical device and biologics patents. Regularly represents branded drug companies. Also has a presence in the electronics and circuitry space. Demonstrates additional strength in advising on complex cross-border disputes.

Established practice offering counsel on commercial transactions involving IP. Also possesses substantial experience in contentious patent matters at district court level and in post-grant proceedings. Clients are drawn from a range of sectors, including financial service, pharmaceutical and technology.

Respected IP group boasting a fine record in patent litigation, acting for clients in the pharmaceutical, life sciences and medical device arenas. Also recognized for its expertise in inter partes reviews and post-grant proceedings.

Well-regarded IP litigation practice that attracts high-profile clients in the life sciences and technology spaces. Enjoys a fine reputation for its work in USPTO proceedings as well as district and federal court litigation. Frequently engaged for its Hatch-Waxman expertise.

One source notes: "The Fenwick team is very good at thinking strategically in our patent litigations and provides clear, logical advice. They stand out compared to other firms in both their knowledge and the depth of their team."

Noted for its global patent litigation and prosecution practice. The team represents an impressive client roster of leading pharmaceutical and technology companies and offers substantial expertise in inter partes review proceedings and Hatch-Waxman litigation. Draws upon international footprint to offer expertise in cross-border matters.

Well-regarded IP practice that acts for clients in a range of patent disputes at trial level and on appeal. Particularly respected for representing a host of notable pharmaceutical manufacturers in Hatch-Waxman and biologics matters. Additional recent matters have involved in acting on disputes in the telecommunications, automotive and consumer products sectors.

Represented Alexion Pharmaceuticals in a patent infringement suit filed by Chugai Pharmaceutical which alleged that Alexion’s ravulizumab product infringes a patent owned by Chugai. The patent at issue concerned a treatment for paroxysmal nocturnal hemoglobinuria, a rare blood disease.

Noted litigation group with proven successes in the patent infringement arena. Members regularly appear before the PTO and federal and district courts in their representations of high-profile life sciences sector clients.

Heavily involved in the consumer electronics sector, litigating disputes before the USPTO and district courts and at the federal level on appeal. Particularly highly regarded for experience acting against nonpracticing entities. Additional expertise in the representation of a range of clients in trademark and copyright matters.

Experienced in an array of industry areas including electrical engineering, computer science, pharmacology and medical devices. Noted trial team, supported by significant capabilities in patent prosecution. Also provides advice on IP issues in corporate transactions, where the firm's multijurisdictional presence is an advantage.

Handles high-stakes patent litigation for a range of clients, particularly those in the life sciences and technology space. Utilizes the firm's wider expertise in cross-border mandates, as well as in corporate and antitrust matters, to provide a holistic offering to clients.

Successfully represented Hospira in a patent infringement dispute with Belcher Pharmaceuticals concerning its formulation of epinephrine, a drug typically used to treat critically ill patients. The Federal Circuit upheld the district court decision finding non-infringement and invalidity.